World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
13342
World Ranking
3419
National Ranking
1587

Overview

Linda S. Wyatt is a researcher affiliated with the National Institutes of Health in the United States. Their research spans multiple fields including Biochemistry, Genetics and Molecular Biology, and Medicine, with specific focuses on Virology, Genetics, Pathology and Forensic Medicine, Animal Science and Zoology, as well as Molecular Biology.

The scientist's work explores various topics such as Poxvirus research and outbreaks, Virus-based gene therapy research, Animal Virus Infections Studies, Bacillus and Francisella bacterial research, Autoimmune Bullous Skin Diseases, Parvovirus B19 Infection Studies, and Systemic Sclerosis and Related Diseases.

Linda S. Wyatt has contributed to several publications in well-known scientific venues. These include:

  • "Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells" (2020, PLoS Pathogens)
  • "Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells" (2021, Journal of Virology)
  • "HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges" (2021, UNC Libraries)
  • "Black Male Youth Raised in Public Systems: Engagement, Healing, Hope". Edited by Sheryl Brissett Chapman, Ralph Belk, Jasilyn Morgan, and Krystal Holland, with Bruce Tyson and Omore Okhomina (2025, Social Work)

The scientist has collaborated with several frequent co-authors, including Bernard Moss, Chen Peng, Shira Glushakow-Smith, Madhu Lal-Nag, and Andrea S. Weisberg. Bernard Moss appears as a co-author on multiple occasions.

Best Publications

  • Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

    Rama Rao Amara;Francois Villinger;John D. Altman;Shari L. Lydy

  • Generation of Recombinant Vaccinia Viruses

    Linda S. Wyatt;Patricia L. Earl;Bernard Moss

  • Isolation of a new herpesvirus from human CD4+ T cells

    Niza Frenkel;Eric C. Schirmer;Linda S. Wyatt;George Katsafanas

  • Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

    Patricia L. Earl;Jeffrey L. Americo;Linda S. Wyatt;Leigh Anne Eller

  • Replication-Deficient Vaccinia Virus Encoding Bacteriophage T7 RNA Polymerase for Transient Gene Expression in Mammalian Cells

    Linda S. Wyatt;Bernard Moss;Shmuel Rozenblatt

  • A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

    Gerd Sutter;Linda S. Wyatt;Patricia L. Foley;Jack R. Bennink

  • Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge

    Linda S. Wyatt;Patricia L. Earl;Leigh Anne Eller;Bernard Moss

  • Preparation of Cell Cultures and Vaccinia Virus Stocks

    Patricia L. Earl;Norman Cooper;Linda S. Wyatt;Bernard Moss

  • Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

    Igor M. Belyakov;Patricia Earl;Amiran Dzutsev;Vladimir A. Kuznetsov

  • Differentiation between two distinct classes of viruses now classified as human herpesvirus 6.

    Eric C. Schirmer;Linda S. Wyatt;Koichi Yamanishi;William J. Rodriguez

  • Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.

    Linda S. Wyatt;Scott T. Shors;Brian R. Murphy;Bernard Moss

  • Overcoming immunity to a viral vaccine by DNA priming before vector boosting.

    Zhi yong Yang;Linda S. Wyatt;Wing pui Kong;Zoe Moodie

  • Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.

    Dan H. Barouch;Sampa Santra;Marcelo J. Kuroda;Jörn E. Schmitz

  • Comparative Efficacy of Recombinant Modified Vaccinia Virus Ankara Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol and/or Env in Macaques Challenged with Pathogenic SIV

    Ilnour Ourmanov;Charles R. Brown;Bernard Moss;Miles Carroll

  • Human herpesvirus 7: antigenic properties and prevalence in children and adults.

    L S Wyatt;W J Rodriguez;N Balachandran;N Frenkel

  • Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques

    Koert J. Stittelaar;Thijs Kuiken;Rik L. de Swart;Geert van Amerongen

  • Human herpesvirus 7 is a constitutive inhabitant of adult human saliva.

    L S Wyatt;N Frenkel

  • Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine

    Rama Rao Amara;James M. Smith;James M. Smith;Silvija I. Staprans;David C. Montefiori

  • Human herpesvirus-6 strain groups: a nomenclature

    D. Ablashi;H. Agut;Z. Berneman;G. Campadelli-Fiume

  • In vitro activation of human herpesviruses 6 and 7 from latency.

    George C. Katsafanas;Eric C. Schirmer;Linda S. Wyatt;Niza Frenkel

  • Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine

    Rama Rao Amara;Francois Villinger;John D Altman;Shari L Lydy;Shari L Lydy

Frequent Co-Authors

Bernard Moss
Bernard Moss National Institutes of Health
Rama Rao Amara
Rama Rao Amara Emory University
Patricia L. Earl
Patricia L. Earl National Institute of Allergy and Infectious Diseases
Harriet L. Robinson
Harriet L. Robinson Emory University
David C. Montefiori
David C. Montefiori Duke University
Francois Villinger
Francois Villinger University of Louisiana at Lafayette
James G. Herndon
James G. Herndon Emory University
Harold M. McClure
Harold M. McClure Emory University
Vanessa M. Hirsch
Vanessa M. Hirsch National Institute of Allergy and Infectious Diseases
Eric C. Schirmer
Eric C. Schirmer University of Edinburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge in Immunology and related healthcare fields, several online degree options offer flexible pathways. One popular route is transitioning through an fnp to acute care np bridge program, which allows nurse practitioners to specialize further in acute care settings. This pathway is ideal for professionals aiming to deepen their clinical expertise while staying current with evolving medical demands.

Accelerated programs, such as accelerated rn to np programs, help registered nurses advance swiftly into nurse practitioner roles, often incorporating coursework relevant to immunology and patient care. These programs are designed for motivated individuals seeking expedited career progression without compromising educational quality.

For those entering nursing from other fields, options like online rn programs for non nurses in Florida provide accessible entry points. These programs support a foundational understanding of biological sciences, essential for immunology studies and clinical practice.

Additionally, absn programs with high acceptance rates offer another route to quickly obtain a Bachelor of Science in Nursing degree. These programs emphasize foundational clinical skills and theoretical knowledge, often incorporating contemporary topics relevant to immunological health.

Exploring these related online degrees can open diverse career pathways—ranging from research to advanced clinical roles—empowering students and professionals to contribute significantly to immunology and healthcare sectors.

Best Scientists Citing Linda S. Wyatt

Trending Scientists

Recently Published Articles